MX9705218A - Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica. - Google Patents

Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica.

Info

Publication number
MX9705218A
MX9705218A MX9705218A MX9705218A MX9705218A MX 9705218 A MX9705218 A MX 9705218A MX 9705218 A MX9705218 A MX 9705218A MX 9705218 A MX9705218 A MX 9705218A MX 9705218 A MX9705218 A MX 9705218A
Authority
MX
Mexico
Prior art keywords
idiopathic
prophylaxis
manufacture
treatment
pharmaceutical composition
Prior art date
Application number
MX9705218A
Other languages
English (en)
Other versions
MXPA97005218A (es
Inventor
Niels Korsgaard
Michael Shalmi
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9705218A publication Critical patent/MX9705218A/es
Publication of MXPA97005218A publication Critical patent/MXPA97005218A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion proporciona nuevos usos de los compuestos de la formula general (I) en donde R1, R4 y R5 son individualmente hidrogeno, hidroxilo, halogeno, trifluorometilo, alquilo inferior, alcoxi inferior (amino terciario) (alcoxi inferior); y R2 y R3 son individualmente hidrogeno o alquilo inferior; o como una sal farmacéuticamente aceptable de los mismos en combinacion con un portador farmacéuticamente aceptable para la fabricacion de una composicion farmacéutica para el tratamiento de profilaxis de ginecomastia idiopática o fisiologico.
MXPA/A/1997/005218A 1995-01-13 1997-07-10 Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica MXPA97005218A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK0042/95 1995-01-13
DK4295 1995-01-13
DK0773/95 1995-06-30
DK77395 1995-06-30
PCT/DK1996/000012 WO1996021442A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia

Publications (2)

Publication Number Publication Date
MX9705218A true MX9705218A (es) 1997-10-31
MXPA97005218A MXPA97005218A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
IL116747A (en) 1999-11-30
AU702407B2 (en) 1999-02-18
CA2208868A1 (en) 1996-07-18
EP0809496A1 (en) 1997-12-03
BR9606754A (pt) 1998-01-06
HUP9800133A3 (en) 1999-12-28
HUP9800133A2 (hu) 1998-12-28
IL116747A0 (en) 1996-05-14
AU4329096A (en) 1996-07-31
US5919812A (en) 1999-07-06
NO973242L (no) 1997-07-11
JPH10511960A (ja) 1998-11-17
CZ212497A3 (en) 1997-11-12
NO973242D0 (no) 1997-07-11
WO1996021442A1 (en) 1996-07-18
CN1168097A (zh) 1997-12-17

Similar Documents

Publication Publication Date Title
MY127718A (en) Dolastatin 10 derivatives.
PL353337A1 (en) Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones
JO2475B1 (en) Glucokinase stimulants
IL133825A0 (en) Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
BG106013A (en) New compounds and compositions as protease inhibitors
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
UA72881C2 (uk) Похідні тієнопіридину, фармацевтична композиція з використанням таких сполук (варіанти), проміжна сполука
YU55602A (sh) Amino derivati dihidro-1,3,5-triazina i njihova terapeutska primena
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
MXPA04005847A (es) Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
MX9705219A (es) Uso de 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes ginecologicos.
NZ528997A (en) Sulfonamides
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
MXPA04006041A (es) Antivirales de piridoquinoxalina.
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
MY124078A (en) Eletriptan hydrobromide monohydrate
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
PL323305A1 (en) Applications of allyl amines
MY136138A (en) Hexacyclic compounds
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
BR9808234A (pt) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas para a produção de uma composição farmacêutica para o tratamento de distúrbios do sono
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.